S

Stenocare A/S
CSE:STENO

Watchlist Manager
Stenocare A/S
CSE:STENO
Watchlist
Price: 1.3 DKK
Market Cap: 26m DKK
Have any thoughts about
Stenocare A/S?
Write Note

Stenocare A/S
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Stenocare A/S
Total Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
S
Stenocare A/S
CSE:STENO
Total Receivables
kr3.7m
CAGR 3-Years
36%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Novo Nordisk A/S
CSE:NOVO B
Total Receivables
kr79.6B
CAGR 3-Years
31%
CAGR 5-Years
25%
CAGR 10-Years
17%
H Lundbeck A/S
CSE:HLUN A
Total Receivables
kr3.6B
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ALK-Abello A/S
CSE:ALK B
Total Receivables
kr924m
CAGR 3-Years
11%
CAGR 5-Years
12%
CAGR 10-Years
N/A
No Stocks Found

Stenocare A/S
Glance View

Market Cap
23.6m DKK
Industry
Pharmaceuticals

Stenocare A/S engages in the cultivation, manufacture, and distribution of medical cannabis products. The Company’s business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. The firm distributes its products through pharmacies and hospitals. Stenocare's head office is located in Randers, Denmark.

STENO Intrinsic Value
0.45 DKK
Overvaluation 66%
Intrinsic Value
Price
S

See Also

What is Stenocare A/S's Total Receivables?
Total Receivables
3.7m DKK

Based on the financial report for Dec 31, 2023, Stenocare A/S's Total Receivables amounts to 3.7m DKK.

What is Stenocare A/S's Total Receivables growth rate?
Total Receivables CAGR 5Y
4%

Over the last year, the Total Receivables growth was -41%. The average annual Total Receivables growth rates for Stenocare A/S have been 36% over the past three years , 4% over the past five years .

Back to Top